BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38879666)

  • 1. CRISPR/Cas9-based genome-wide screening for metastasis ability identifies FCGR1A regulating the metastatic process of ovarian cancer by targeting LSP1.
    Qi Y; Zhu W; Mo K; Jiang H
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):306. PubMed ID: 38879666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumor 1 (
    Han Y; Song C; Zhang T; Zhou Q; Zhang X; Wang J; Xu B; Zhang X; Liu X; Ying X
    Cell Cycle; 2020 Oct; 19(20):2662-2675. PubMed ID: 32892698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin/HTR1E signaling blocks chronic stress-promoted progression of ovarian cancer.
    Qin X; Li J; Wang S; Lv J; Luan F; Liu Y; Chen Y; Chen X; Zhao Y; Zhu J; Piao Y; Zhang W; Shi Y; Xiang R; Qu P; Wang L
    Theranostics; 2021; 11(14):6950-6965. PubMed ID: 34093864
    [No Abstract]   [Full Text] [Related]  

  • 4. Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.
    Xu H; Ding Y; Yang X
    Biomed Res Int; 2021; 2021():6619730. PubMed ID: 34250088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low PDE4A expression promoted the progression of ovarian cancer by inducing Snail nuclear translocation.
    Wang J; Gu Q; Liu Y; Huang X; Zhang J; Liu B; Li R; Linghu H
    Exp Cell Res; 2024 Jun; 439(2):114100. PubMed ID: 38797258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA AOC4P suppresses epithelial ovarian cancer metastasis by regulating epithelial-mesenchymal transition.
    Lin X; Tang X; Zheng T; Qiu J; Hua K
    J Ovarian Res; 2020 Apr; 13(1):45. PubMed ID: 32334623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

  • 8. CircAGFG1 Promotes Ovarian Cancer Progression Through the miR-409-3 p/ZEB1 Axis.
    Luo J; Zhong H; Guo M; Xiao P; Cao R; Zhao M; Jing Y
    Technol Cancer Res Treat; 2024; 23():15330338241252423. PubMed ID: 38752261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells.
    Faddaoui A; Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Ghani K; Bachvarov D
    Cell Cycle; 2017 Apr; 16(7):693-706. PubMed ID: 28278050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition.
    Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Lu H; Sisinni L; Lettini G; Gabra H; Landriscina M; Esposito F
    Cell Death Dis; 2016 Dec; 7(12):e2522. PubMed ID: 27977010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA SNHG1 stimulates ovarian cancer progression by modulating expression of miR-454 and ZEB1.
    Wu Y; Zhu B; Yan Y; Bai S; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
    Mol Oncol; 2021 May; 15(5):1584-1596. PubMed ID: 33641229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Yu J; Han Q; Cui Y
    Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Overexpression of Keratin 23 Promotes Migration of Ovarian Cancer via Epithelial-Mesenchymal Transition.
    Ren M; Gao Y; Chen Q; Zhao H; Zhao X; Yue W
    Biomed Res Int; 2020; 2020():8218735. PubMed ID: 33204716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
    Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
    J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA AC005224.4/miR-140-3p/SNAI2 regulating axis facilitates the invasion and metastasis of ovarian cancer through epithelial-mesenchymal transition.
    Xiong T; Wang Y; Zhang Y; Yuan J; Zhu C; Jiang W
    Chin Med J (Engl); 2023 May; 136(9):1098-1110. PubMed ID: 36939239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway.
    Chen L; Qian J; You Q; Ma J
    Bioengineered; 2021 Dec; 12(2):10089-10100. PubMed ID: 34724866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
    Sun Z; Gao S; Xuan L; Liu X
    J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa_circ_0001756 promotes ovarian cancer progression through regulating IGF2BP2-mediated RAB5A expression and the EGFR/MAPK signaling pathway.
    Ji J; Li C; Wang J; Wang L; Huang H; Li Y; Fang J
    Cell Cycle; 2022 Apr; 21(7):685-696. PubMed ID: 35113003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis.
    Xie W; Zhang L; Shen J; Lai F; Han W; Liu X
    BMC Cancer; 2024 May; 24(1):551. PubMed ID: 38693472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIPK4 Promotes Cell Invasion and the Epithelial-Mesenchymal Transition in Ovarian Cancer.
    Hua L; Wu JH; Xu JY; Wu SG; Zhou J
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):368. PubMed ID: 38179758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.